|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MSDS   | : | 2H-1,2,4-Benzothiadiazine-3-carboxylic acid,
7-(aminosulfonyl)-6-chloro-3,4-dihydro- 2-methyl-,
methyl ester, 1,1-dioxide
| | CAS   | : | 42583-55-1 | | SYNONYMS   | : | * Carmetizide
* DU-5747
|
| |
|
|
|
|
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : DK8180000
CHEMICAL NAME : 2H-1,2,4-Benzothiadiazine-3-carboxylic acid,
7-(aminosulfonyl)-6-chloro-3,4-dihydro- 2-methyl-,
methyl ester, 1,1-dioxide
CAS REGISTRY NUMBER : 42583-55-1
BEILSTEIN REFERENCE NO. : 0715143
LAST UPDATED : 199612
DATA ITEMS CITED : 9
MOLECULAR FORMULA : C10-H12-Cl-N3-O6-S2
MOLECULAR WEIGHT : 369.82
WISWESSER LINE NOTATION : T66 BSWN EM DHJ C1 DVO1 HG ISZW
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Carmetizide
* DU-5747
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,231,1973
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,231,1973
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,231,1973
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,231,1973
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,231,1973
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,231,1973
** REPRODUCTIVE DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 6 gm/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,267,1973
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1500 mg/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,267,1973
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 1500 mg/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,267,1973
*** END OF RECORD ***
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| | NAME | CAS |
|
o-Benzoquinone
| 583-63-1 |
|
p-Benzoquinone,2,5-bis((4-(diethylamino)butyl)amino)-
| 102944-92-3 |
|
1,2,4-Benzothiadiazepine,2,5-dihydro-2-methyl-3-(p-nitrophenyl)-, 1,1-dioxide
| 40431-27-4 |
|
1,2,4-Benzothiadiazepine,2,5-dihydro-2-methyl-3-phenyl-, 1,1-dioxide
| 40431-23-0 |
|
1,2,4-Benzothiadiazepine,2,5-dihydro-2-methyl-3-propyl-, 1,1-dioxide
| 46781-71-9 |
|
2H-1,2,4-Benzothiadiazin-3-amine, 1,1-dioxide
| 16288-74-7 |
|
1H-2,1,4-Benzothiadiazine-3-carbamic acid, methylester
| 33082-92-7 |
|
2H-1,2,4-Benzothiadiazine-3-carboxamide,N-(3-chlorophenyl)-, 1,1-dioxide
| 57864-87-6 |
|
2H-1,2,4-Benzothiadiazine-3-carboxylic acid,7-(aminosulfonyl)-6-chloro-3,4-dihydro- 2-methyl-,methyl ester, 1,1-dioxide
| 42583-55-1 |
|
2H-1,2,4-Benzothiadiazine-3-carboxylic acid,2-((4-(aminosulfonyl)phenyl)sulfonyl)hydrazide,1,1-dioxide
| 57864-99-0 |
|
2H-1,2,4-Benzothiadiazine-3-carboxylic acid,3,4-dihydro-7-sulfamoyl-6-(trifluoromethyl)-,1,1-dioxide
| 393-21-5 |
|
2H-1,2,4-Benzothiadiazine-3-carboxylic acid,3,4-dihydro-7-sulfamoyl-6-(trifluoromethyl)-,1,1-dioxide, compd. with2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy) ethanol (2:1)
| 393-21-5 |
|
p-Benzoquinone,2,5-bis((2-(diethylamino)ethyl)amino)-
| 23419-59-2 |
|
2H-1,2,4-Benzothiadiazine-3-carboxylic acid,1,1-dioxide
| 57864-78-5 |
|
2H-1,2,4-Benzothiadiazine-3-carboxylic acid,2-((4-methylphenyl)sulfonyl)hydrazide, 1,1-dioxide
| 57864-94-5 |
|
4H-1,2,4-Benzothiadiazine, 3-chloro-4-ethyl-,1,1-dioxide
| 107089-77-0 |
|
2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-,1,1-dioxide
| 364-98-7 |
|
4H-1,2,4-Benzothiadiazine, 3-chloro-4-methyl-,1,1-dioxide
| 107089-76-9 |
|
2H-1,2,4-Benzothiadiazine,7-chloro-3-(4-methyl-1-piperazinyl)-, 1,1-dioxide
| 59943-31-6 |
|
4H-1,2,4-Benzothiadiazine, 3-chloro-4-phenyl-,1,1-dioxide
| 107089-78-1 |
|
2H-1,2,4-Benzothiadiazine, 6,7-dichloro-, 1,1-dioxide
| 359-87-5 |
|
2H-1,2,4-Benzothiadiazine, 6,7-dichloro-3-methyl-,1,1-dioxide
| 364-96-5 |
|
2H-1,2,4-Benzothiadiazine,3,4-dihydro-6-chloro-3-(alpha-methylbenzyl)-7-sulfamoyl-, 1,1-dioxide
| 1824-52-8 |
|
p-Benzoquinone,2,5-bis((5-(diethylamino)pentyl)amino)-
| 102808-97-9 |
|
2H-1,2,4-Benzothiadiazine, 3,4-dihydro-6,7-dichloro-,1,1-dioxide
| 359-86-4 |
|
2H-1,2,4-Benzothiadiazine,3,4-dihydro-6,7-dichloro-3-methyl-, 1,1-dioxide
| 446-62-8 |
|
2H-1,2,4-Benzothiadiazine, 3,4-dihydro-, 1,1-dioxide
| 359-84-2 |
|
4H-1,2,4-Benzothiadiazine,3-(2,3-dihydro-3,3,5-trimethyl-1H-pyrazol-1-yl)-4-ethyl-, S,S-dioxide
| 107089-89-4 |
|
4H-1,2,4-Benzothiadiazine,3-(2,3-dihydro-3,3,5-trimethyl-1H-pyrazol-1-yl)-4-methyl-, S,S-dioxide
| 107089-88-3 |
|
4H-1,2,4-Benzothiadiazine,3-(2,3-dihydro-3,3,5-trimethyl-1H-pyrazol-1-yl)-4-phenyl-, S,S-dioxide
| 107089-90-7 |
|
4H-1,2,4-Benzothiadiazine,3-(3,5-dimethyl-1H-pyrazol-1-yl)-4-ethyl-,1,1-dioxide
| 107089-83-8 |
|
4H-1,2,4-Benzothiadiazine,3-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methyl-,1,1-dioxide
| 107089-82-7 |
|
4H-1,2,4-Benzothiadiazine,3-(3,5-dimethyl-1H-pyrazol-1-yl)-4-phenyl-,1,1-dioxide
| 107089-84-9 |
|
2H-1,2,4-Benzothiadiazine, 1,1-dioxide
| 359-85-3 |
|
p-Benzoquinone,2,5-bis((3-(diethylamino)propyl)amino)-
| 1245-79-0 |
|
|
|
|
|